A retrospective targeted next-generation sequencing study of histopathologically verified malignant CRC patient tumor samples from the University of the Philippines Manila National Institutes of Health [15] identified both canonical and novel or reported but uncharacterized somatic mutations in KRAS and NRAS. Here, NRAS is linked to neoplasm.